Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Pass Below 50-Day Moving Average – Here’s Why

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) shares passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.23 and traded as low as $9.72. Ono Pharmaceutical shares last traded at $9.72, with a volume of 2,331 shares trading hands.

Ono Pharmaceutical Stock Performance

The business’s fifty day moving average price is $10.23 and its 200-day moving average price is $12.34. The stock has a market cap of $4.57 billion, a PE ratio of 9.35 and a beta of 0.59. The company has a debt-to-equity ratio of 0.15, a quick ratio of 2.80 and a current ratio of 3.22.

Ono Pharmaceutical (OTCMKTS:OPHLF) last issued its quarterly earnings data on Monday, February 3rd. The company reported $0.21 earnings per share for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.14%.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.